Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Özlem Türeci

Showing results (1-10 of 125) with videos related to

Pageof 13
Sort By:
EMBO Molecular Medicine|September 17, 2021
Racing for a SARS-CoV-2 vaccineÖzlem Türeci, Uğur Şahin
Science (New York, N.Y.)|March 24, 2018
Personalized vaccines for cancer immunotherapyUgur Sahin, Özlem Türeci
Nature Reviews. Drug Discovery|September 20, 2014
mRNA-based therapeutics--developing a new class of drugsUgur Sahin, Katalin Karikó, Özlem Türeci
Annual Review of Medicine|January 30, 2019
Harnessing Tumor Mutations for Truly Individualized Cancer VaccinesMathias Vormehr, Özlem Türeci, Ugur Sahin
Oncoimmunology|July 4, 2015
Retrieval of functional TCRs from single antigen-specific T cells: Toward individualized TCR-engineered therapiesTana Omokoko, Petra Simon, Özlem Türeci, et al.
Current Opinion in Immunology|April 19, 2011
Tumor vaccination using messenger RNA: prospects of a future therapySebastian Kreiter, Mustafa Diken, Abderraouf Selmi, et al.
Nature Reviews. Drug Discovery|February 2, 2022
Identification of neoantigens for individualized therapeutic cancer vaccinesFranziska Lang, Barbara Schrörs, Martin Löwer, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|September 2, 2019
Personalized Neo-Epitope Vaccines for Cancer TreatmentMathias Vormehr, Mustafa Diken, Özlem Türeci, et al.
Current Opinion in Immunology|December 31, 2015
Mutanome directed cancer immunotherapyMathias Vormehr, Mustafa Diken, Sebastian Boegel, et al.
Methods in Molecular Biology (Clifton, N.J.)|December 18, 2016
Discovery and Subtyping of Neo-Epitope Specific T-Cell Responses for Cancer Immunotherapy: Addressing the MutanomeMustafa Diken, Mathias Vormehr, Christian Grunwitz, et al.
Pageof 13

Showing results (1-10 of 125) with videos related to

Sort By:
Pageof 13
EMBO Molecular Medicine|September 17, 2021
Racing for a SARS-CoV-2 vaccineÖzlem Türeci, Uğur Şahin
Science (New York, N.Y.)|March 24, 2018
Personalized vaccines for cancer immunotherapyUgur Sahin, Özlem Türeci
Nature Reviews. Drug Discovery|September 20, 2014
mRNA-based therapeutics--developing a new class of drugsUgur Sahin, Katalin Karikó, Özlem Türeci
Annual Review of Medicine|January 30, 2019
Harnessing Tumor Mutations for Truly Individualized Cancer VaccinesMathias Vormehr, Özlem Türeci, Ugur Sahin
Oncoimmunology|July 4, 2015
Retrieval of functional TCRs from single antigen-specific T cells: Toward individualized TCR-engineered therapiesTana Omokoko, Petra Simon, Özlem Türeci, et al.
Current Opinion in Immunology|April 19, 2011
Tumor vaccination using messenger RNA: prospects of a future therapySebastian Kreiter, Mustafa Diken, Abderraouf Selmi, et al.
Nature Reviews. Drug Discovery|February 2, 2022
Identification of neoantigens for individualized therapeutic cancer vaccinesFranziska Lang, Barbara Schrörs, Martin Löwer, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|September 2, 2019
Personalized Neo-Epitope Vaccines for Cancer TreatmentMathias Vormehr, Mustafa Diken, Özlem Türeci, et al.
Current Opinion in Immunology|December 31, 2015
Mutanome directed cancer immunotherapyMathias Vormehr, Mustafa Diken, Sebastian Boegel, et al.
Methods in Molecular Biology (Clifton, N.J.)|December 18, 2016
Discovery and Subtyping of Neo-Epitope Specific T-Cell Responses for Cancer Immunotherapy: Addressing the MutanomeMustafa Diken, Mathias Vormehr, Christian Grunwitz, et al.
Pageof 13